Author

Ailsa L Hart 1

1 St Mark?s Hospital and Academic Institue,London,United Kingdom

ACTIVITY OF TRANSFORMING GROWTH FACTOR (TGF) β1 AND BONE MORPHOGENIC PROTEIN (BMP) IN COLONIC EPITHELIUM ESCAPES THE INHIBITION OF SMALL MOTHERS AGAINST DECAPENTAPLEGIC (SMAD) 7 IN COLITIS-ASSOCIATED CANCER

Pramodh Chitral Chandrasinghe, Biancastella Cereser, Morgan Moorghen, Lisa Del Bel Belluz, Ibrahim Al Bakir,, Ailsa L Hart, Justin Stebbing, Janindra Warusavitarne

ADHERENCE TO TOPICAL THERAPY IN ULCERATIVE COLITIS

Muntashir Rahman Shuvo, Philip Anthony Hendy, Lawrence Penez, Ailsa L Hart

An overview of early ulcerative colitis

Ailsa L Hart

An overview of early ulcerative colitis

Ailsa L Hart

APPENDICEAL DENDRITIC CELLS ARE PRO-INFLAMMATORY, DRIVE GUT-SPECIFIC T-CELL RESPONSES AND ARE ALTERED IN ULCERATIVE COLITIS

Nuha A. Yassin, Suchira Sarkar, Alan Baird, Ailsa L Hart, Robin KS Phillips, Stella C. Knight, Elizabeth Rebecca Mann, Hafid Omar Al-Hassi, Gui-Han Lee

Arena - Expanding horizons: Will oral therapies change the IBD treatment landscape? (Arena Pharmaceuticals)

Stefan Schreiber, Ailsa L Hart, Laurent Peyrin-Biroulet

Biologics and perioperative morbidity

Ailsa L Hart

BODY COMPOSITION PROFILE IS ASSOCIATED WITH ANTI-TNF RESPONSE IN CROHN’S DISEASE PATIENTS

Nik Ding, George Malietzis, Thenugan Ganeshanathan, Man Yip, Lawrence Penez, Simon M. Gabe, Phillip Fai Chung Lung, John T. Jenkins, Ailsa L Hart

BODY COMPOSITION PROFILE: A PREDICTOR OF THERAPEUTIC OUTCOME IN PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE.

Nik Ding, George Malitezis, Philip F.C. Lung, Wai Man Yip, Lawrence Penez, Thenugan Ganeshanathan, Simon M. Gabe, Ian Jenkins, Ailsa L Hart

CHARACTERISTICS AND REAL WORLD TREATMENT HISTORY OF PATIENTS TREATED WITH TOFACITINIB FOR ULCERATIVE COLITIS IN EUROPE

Alessandro Armuzzi, Nadir Mammar, Benjamin Hoskin, Fritha Hennessy, Puza P. Sharma, Gary Milligan, Ailsa L Hart, Joseph C. Cappelleri, Axel Dignass, John C. Woolcott

Item 1 - 10 / 66
1
2 3 4 5 6 7